PRO® and Siemens Healthineers' Magnetom Free.Max - TORONTO, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) ("Profound” or the "Company”), a commercial-stage medical ...
Recognizing TULSA is being used by urologists to treat an unrivalled variety of prostate cancer and/or BPH patients, Profound is developing a novel set of software modules under the TULSA-AI ® brand ...
The goals and objectives of the Musculoskeletal Radiology and Imaging Fellowship program are to train the next generation of leaders in musculoskeletal imaging with an emphasis on clinical, teaching, ...